Article info

Download PDFPDF
Extended report
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study
  1. Correspondence to Dr M van den Broek, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands; m.van_den_broek{at}lumc.nl
View Full Text

Citation

van den Broek M, Klarenbeek NB, Dirven L, et al
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

Publication history

  • Accepted March 21, 2011
  • First published April 24, 2011.
Online issue publication 
June 28, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.